🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphoma | Blood Neoplasia | American Society of Hematology ashpublications.org/bloodneoplasia…

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine nejm.org/doi/full/10.10…

PURPOSETo evaluate the survival benefit of chemotherapy intensification in older patients with AML who have not achieved a measurable residual disease (MRD)–neg… Source: Journal of Clinical Oncology search.app/7gLVZoSupbLzRk…

Key PointsThe overall response rate for low-dose subcutaneous decitabine was 33% in this prospective clinical trial of 21 patients with myelofibrosis.A hig Source: American Society of Hematology search.app/fXaVMKne4NPKyg…

The new thrombophilia, MGTS just got more interesting, and complicated! Here is a new paper in NEJM from our group on the challenges of recognizing this disorder: nejm.org/doi/full/10.10… Couple of other recent papers on MGTS: nejm.org/doi/abs/10.105… ashpublications.org/blood/article/…

Sad and painful. search.app/nNtjoUowrfza5q…

OHSU’s Brian Druker on morale, cost-cutting, and the plan to acquire Legacy Health - OPB opb.org/article/2024/1…

B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading ca… Source: The New England Journal of Medicine search.app/Zw4qC4WRvd9gdA…

Daratumumab, an anti-CD38 monoclonal antibody, has been approved for the treatment of multiple myeloma. Data are needed regarding the use of daratumumab for hig… Source: The New England Journal of Medicine search.app/ZGncNoBJaprtUX…

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/…

T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities | Blood | American Society of Hematology ashpublications.org/blood/article/…

High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience - González‐Calle - 2024 - HemaSphere - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/he…

Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/…

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy | Blood | American Society of Hematology ashpublications.org/blood/article/…

Primary large B-cell lymphomas of immune-privileged sites | Blood | American Society of Hematology ashpublications.org/blood/article/…

American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj…

👉👉👉Delighted to share our new report just out in 🚨 PubMed ➡️ our multi-disciplinary focus on transfusions with rare antibody profiles during leukemia management led by Dr Grace Park and Dr Hima Atluri, MD || Guillermo Montalban-Bravo Naveen Pemmaraju, MD #leusm | sciencedirect.com/science/articl…

Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/…